What this means
Researchers want to learn how frailty affects outcomes and quality of life in adults with gynecologic cancer. The study is still recruiting, so no results have been posted yet.
Plain-English summary written by an AI model from the registry listing.
- Status
- Recruiting
- Who can join
- Ages 18 and over
- Where
- 2 sites, including California, Massachusetts
The science
- Registered title
- PROmOting Gynecologic Cancer Patients With Frailty to Achieve Functional Recovery
- Trial ID
- NCT06089083 ↗
- Phase
- Not applicable
- Study type
- observational
- Conditions
- Malignant Female Reproductive System Neoplasm, Gynecologic Cancer, Gynecologic Neoplasm
- What is tested
- Physical function assessment, Self-reported Assessments and Questionnaires, Surgery (Standard of Care, Non-Interventional)
- Sponsor
- University of California, San Francisco
- Ages
- 18 Years to no maximum
- Dates
- First posted Oct 18, 2023 · updated Jan 26, 2026
Registry summary
This study seeks to understand how frailty, a term that describes people who are more vulnerable stressors such as a new medical problem, affects the outcomes and quality of life in adult patients with gynecologic cancer.
Sites (2)
- University of California, San Francisco, San Francisco, California, United States
- Dana Farber Cancer Institute, Boston, Massachusetts, United States